It’s last call for presentations at the Midwest Drug Development conference, officials announced today.
Only 10 slots remain open in the two-day slate of early- and mid-stage technologies that will be presented to guests from the worlds of biomedical therapeutics and investor groups.
The MidWest Drug Development Conference is now accepting registrations to attend a two-day event focused on highlighting the best early- and mid-stage therapeutic technologies that Midwestern universities have to offer.
The Midwest Drug Development Conference, a new biomedical partnering event, will come to Omaha next year, officials at the University of Nebraska Medical Center and its technology transfer and commercialization office, UNeMed, announced today.
